Kallyope Review (January 2026)
At Kallyope, we are leveraging insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders.
At Kallyope, we are leveraging insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders.
What is Kallyope's Revenue?
Kallyope's estimated revenue is $29M.
What does Kallyope do?
At Kallyope, we are leveraging insights into neural signaling pathways and developing innovative medicines for the treatment of migraine and metabolic disorders.
How fast is Kallyope growing?
Kallyope has grown by 44.9% in the last 3 months according to SimilarWeb.
How do people find Kallyope?
45% of visitors come directly to Kallyope. 33% find them through search engines. 13% discover them through social media.
How do people interact with Kallyope?
Last month, Kallyope received 2.3K visitors who spent an average of 00:17 minutes on the website and visited 1.6 different pages per session. Overall, 42% of people bounce on the first visit.
Who uses Kallyope?
Kallyope's top market is US and they receive 81% of visitors from there. The 2nd is IN with 19%.
Traffic Growth (last 3 months)
Traffic Sources
Top Countries
Technology detection powered by advanced web analysis
Powered byTechlist.aiValeritas
Discover V-Go, a lightweight, wearable insulin delivery device designed to simplify basal-bolus therapy for adults with diabetes.More
Connectiverx
ConnectiveRx supports patients, keeps medication affordable and creates programs that make it easier to stay on medication, all from one source. More
Arvinas
Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.More
Celularity
Diaceutics
Diaceutics have worked on every Precision Medicine brought to market in partnership with leading pharmaceuticals. #bettertestingbettertreatment.More